Pages with the most categories
Jump to navigation
Jump to search
Showing below up to 18 results in range #1 to #18.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
- Arthur Harden (2 categories)
- University of Oklahoma (2 categories)
- William John Young (2 categories)
- Head to head comparison of short term Treatment with the NAD+ Precursor Nicotinamide Mononucleotide(NMN) and 6 weeks of exercise in obese female mice (2 categories)
- NAD+ (2 categories)
- Conrad Elvehjem (2 categories)
- Nicotinamide mononucleotide , a key NAD+ intermediate , treats the pathophysiology of diet- and age- induced diabetes in mice (2 categories)
- Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice (2 categories)
- Harvard (2 categories)
- Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men (2 categories)
- Washington University (2 categories)
- Sirtuins (2 categories)
- David Sinclair (2 categories)
- Nicotinamide mononucleotide (NMN) supplementation rescues cerebromicrovascular endothelial function and neurovascular coupling responses and improves cognitive function in aged mice (2 categories)
- Oriental Yeast Company (2 categories)
- Shin-ichiro Imai (2 categories)
- Keio University (2 categories)
- University of New South Wales (2 categories)